STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs

An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.

CryptoAlerta — análise de criptomoedas e mercado em tempo real